PainChek Expanded Memory Care Licensing Agreement
The health technology firm has grown its partnership with Sabra Health Care to include 23 care communities.
Updated on Oct. 13, 2026 in Alzheimer’s
Live Poll
Do you think rapid expansion of new health technology in local care facilities is generally beneficial?
PainChek has expanded its commercial agreement with Sabra Health Care, moving from two initial facilities to 23 communities across the United States. This expansion across five operators involves 808 contracted memory care licences.
Why it matters
The deal aims to streamline the adoption of pain assessment technology by reducing contractual and cost barriers for senior housing operators. Sabra Health Care is systematically introducing the platform across its broader senior housing portfolio.
The rollout covers 23 communities operated by five firms, with 808 total memory care licences now under contract. This effort remains part of a broader potential market for PainChek estimated at 1.2 million licences worth A$100 million.
The players
PainChek
PainChek is a health technology company that provides clinical assessment tools for pain management.
Sabra Health Care
Sabra Health Care is a real estate investment trust that invests in properties within the healthcare sector.
The Claiborne
The Claiborne is a senior living provider that operates seven of the communities included in the expansion.
Phoenix Senior Living
Phoenix Senior Living is a company that manages four of the memory care communities involved in the agreement.
The details
Sabra Health Care is facilitating this rollout to integrate advanced pain monitoring tools into memory care settings. The initiative involves operators including The Claiborne, HDG, AgeWell, Phoenix Senior Living, and Traditions Senior Living, which together manage 192 total communities.
Timeline
PainChek signed its master services agreement with Sabra in April 2026.
Implementation and licence activation are targeted for completion by 31 December 2026.
Health Landscape
This integration follows a pattern set by the CMS long-term care quality assurance requirements, which necessitate robust clinical documentation standards in skilled nursing and memory care. The agreement marks a significant shift toward the digital transformation of pain management protocols in specialized housing.
Residents in these 23 communities may benefit from more precise pain assessments, potentially leading to more accurate medical treatments for those with cognitive impairments. The partnership removes financial hurdles that previously limited operator access to this specialized diagnostic software.
The takeaway
Digital assessment tools are increasingly becoming standard in memory care to improve patient outcomes and facility compliance. Implementing such technology can help healthcare providers bridge gaps in pain detection for residents unable to self-report their symptoms.
What happens next
PainChek has set a target deadline of 31 December 2026 to complete staff training and finalize licence activation at all 23 designated communities.
Further reading
Learn more about the latest innovations in Alzheimer’s care technology and clinical management.
Source note: This article includes information reported by Small Caps.
Live Poll
Do you think rapid expansion of new health technology in local care facilities is generally beneficial?
